Healthcare Sales & Marketing Network News: Elan

Searching News Database: Elan

Your search returned too many results! The most recent 500 items are shown below:

HSMN NewsFeed - 21 Sep 2023
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
Devices Endocrinology Regulatory

HSMN NewsFeed - 30 Aug 2023
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
Biopharmaceuticals Litigation Licensing

HSMN NewsFeed - 25 Aug 2023
Medtronic receives CE Mark approval for Inceptiv(TM) spinal cord stimulator with closed-loop sensing to treat chronic pain
Devices Neurosurgery Regulatory

HSMN NewsFeed - 20 Jul 2023
MediView Receives FDA 510(k) Clearance for XR90 Augmented Reality-Based Visualization and Navigation Platform
Devices Surgery FDA

HSMN NewsFeed - 22 Jun 2023
Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 19 Jun 2023
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Jun 2023
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian(R) MRI-Guided Radiation Therapy System
Devices Oncology

HSMN NewsFeed - 25 May 2023
Medtronic to acquire wearable insulin patch maker EOFlow
Devices Endocrinology Mergers & Acquisitions

HSMN NewsFeed - 4 May 2023
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte(TM) in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Apr 2023
Soligenix Provides Regulatory Update on HyBryte(TM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 15 Mar 2023
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 3 Mar 2023
Aadi Bioscience Announces Leadership Transition
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Feb 2023
Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Devices Cardiology Regulatory

HSMN NewsFeed - 14 Feb 2023
Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte(TM) New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Jan 2023
FDA Agrees to Expanded Access Program for the BioVentrix(R) Revivent TC(R) System for the Treatment of Ischemic Heart Failure
Devices Cardiology FDA

HSMN NewsFeed - 4 Jan 2023
Monica Shaw appointed CEO of Oncopeptides - Jakob Lindberg assumes position as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Dec 2022
Koya Medical Announces the Addition of Chief Medical Officer Dr. Thomas Maldonado to Their Executive Leadership Team
Devices Personnel

HSMN NewsFeed - 22 Nov 2022
U.S. Food and Drug Administration Approves CSL's Hemgenix(R) eEtranacogene dezaparvovec-drlb), the First Gene Therapy for Hemophilia B
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Nov 2022
Upstaza(TM) Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA
Regenerative Medicine Neurology Regulatory

HSMN NewsFeed - 15 Nov 2022
Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.
Devices Endocrinology Product Launch

HSMN NewsFeed - 24 Oct 2022
Medtronic Announces Intention to Separate its Combined Patient Monitoring and Respiratory Interventions Businesses
Devices Monitoring Mergers & Acquisitions

HSMN NewsFeed - 17 Oct 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Devices Cardiology FDA

HSMN NewsFeed - 26 Sep 2022
Innocoll and DURECT Announce U.S. launch of POSIMIR(R)
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 20 Sep 2022
Medtronic receives FDA clearance for expanded indication of LINQ II(TM) insertable cardiac monitor for use in pediatric patients ages 2 and older
Devices Cardiology Monitoring FDA

HSMN NewsFeed - 15 Sep 2022
BrainStorm Cell Therapeutics Announces Peer Reviewed Publication of Results from the NurOwn(R) Phase 2 Progressive MS Trial in Multiple Sclerosis Journal
Regenerative Medicine Neurology

HSMN NewsFeed - 9 Sep 2022
Nouscom Strengthens Leadership Team with the Appointments of Sven Gogov, MD, as Chief Medical Officer and Maria Arce-Tomas, PhD, as VP, Head of Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 31 Aug 2022
Medtronic announces partnership with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearable for continuous remote patient monitoring from in-hospital to home
Devices Monitoring Distribution

HSMN NewsFeed - 30 Aug 2022
Medtronic completes acquisition of Affera
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 23 Aug 2022
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
Devices Oncology

HSMN NewsFeed - 15 Aug 2022
Alternative Pathway Blocker Anti-Bb Antibody (NM8074) Receives US FDA Clearance to Start Efficacy Trial in C3 Glomerulopathy (C3G) Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Jul 2022
Checkpoint Surgical launches Checkpoint Edge(TM) Nerve Cutting Kit, extending the company's intraoperative nerve care portfolio
Devices Surgery Product Launch

HSMN NewsFeed - 21 Jul 2022
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO(R) (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 19 Jul 2022
Saitama Medical University International Medical Center Selects MRIdian(R) MRI-Guided Radiation Therapy System
Devices Oncology

HSMN NewsFeed - 14 Jul 2022
Medtronic receives FDA clearance for next-generation UNiD(TM) Spine Analyzer with degenerative spine surgery predictive model
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 14 Jul 2022
Study shows that selection of breast cancer patients for adjuvant bisphosphonate therapy based on Inbiomotion's MAFTEST(R) reduces the risk of death in comparison with current clinical guidance
Diagnostics Oncology

HSMN NewsFeed - 30 Jun 2022
Smith & Nephew announces first robotic-assisted surgery using its LEGION(TM) CONCELOC(TM) Cementless Total Knee System
Devices Orthopaedic

HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 27 Jun 2022
Centerline Biomedical Raises $33 Million in Series B Financing
Devices Surgery Venture Capital

HSMN NewsFeed - 27 Jun 2022
Medtronic Board appoints Lidia Fonseca as a new director
Devices Personnel

HSMN NewsFeed - 24 Jun 2022
BioMarin Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Jun 2022
Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Jun 2022
MicroTransponder Raises $53M, Appoints New CEO
Devices Neurology Personnel Venture Capital

HSMN NewsFeed - 9 Jun 2022
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
Devices Oncology

HSMN NewsFeed - 7 Jun 2022
BD Names Simon Campion as Medical Segment President
Devices Personnel

HSMN NewsFeed - 7 Jun 2022
Shin-Matsudo Central General Hospital Select's ViewRay's MRIdian(R) MRI-Guided Radiation Therapy System to Expand Access to Precision Radiation Therapy
Devices Oncology

HSMN NewsFeed - 2 Jun 2022
Henry Ford Health Becomes the First Center to Treat Patients with ViewRay's MRIdian A3i System
Devices Oncology

HSMN NewsFeed - 1 Jun 2022
CytoSorbents Partners with Nikkiso to Distribute the PureADJUST Hemoperfusion Blood Pump and Supplies in 14 Countries
Devices Distribution

HSMN NewsFeed - 31 May 2022
Sapience Therapeutics Announces $41 Million Series B Financing to Advance Pipeline of Peptide Therapeutics Targeting Protein-Protein Interactions
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 20 May 2022
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza(TM) for the Treatment of AADC Deficiency
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 May 2022
EuroPCR: Medtronic renal denervation system shows better blood pressure control with significantly more time in target range
Devices Interventional Cardiology

HSMN NewsFeed - 13 May 2022
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
Devices Interventional Cardiology FDA

HSMN NewsFeed - 13 May 2022
Medtronic completes acquisition of Intersect ENT
Devices Mergers & Acquisitions

HSMN NewsFeed - 9 May 2022
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
Devices Urology Venture Capital

HSMN NewsFeed - 5 May 2022
XII Medical Completes $30 Million Series A Financing
Devices Venture Capital

HSMN NewsFeed - 3 May 2022
UCI Health Adopts ViewRay(R) MRIdian(R) MRI-Guided Radiation Therapy System
Devices Oncology

HSMN NewsFeed - 21 Apr 2022
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
Devices Interventional Acquisitions

HSMN NewsFeed - 20 Apr 2022
ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology
Devices Ophthalmology FDA

HSMN NewsFeed - 19 Apr 2022
Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 14 Apr 2022
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Apr 2022
Jazz Pharmaceuticals and Werewolf Therapeutics Announce Exclusive Global License and Collaboration Agreement to Develop WTX-613, a Differentiated, Conditionally-Activated IFNα INDUKINE(TM) Molecule
Biopharmaceuticals Licensing

HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 17 Mar 2022
Medtronic appoints new Operating Unit Presidents
Devices Personnel

HSMN NewsFeed - 16 Mar 2022
First U.S. trial using GI Genius(TM) intelligent endoscopy module shows 50% reduction in missed colorectal polyps with artificial intelligence (AI) technology versus standard colonoscopy
Devices Gastroenterology

HSMN NewsFeed - 15 Mar 2022
University Hospital Agostino Gemelli Treats its 1,000th Patient Using MRIdian(R) MRI-Guided Radiation Therapy
Devices Oncology

HSMN NewsFeed - 15 Mar 2022
Neuraxpharm appoints Tom Coogan as new Country Manager for Ireland
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Mar 2022
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreements for Evaluation of Darovasertib and Crizotinib Combination in Metastatic Uveal Melanoma and Additional cMET-Driven Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Feb 2022
Medtronic Announces Launch of NuVent(TM) Eustachian Tube Dilation Balloon
Devices Interventional Product Launch

HSMN NewsFeed - 25 Feb 2022
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 25 Feb 2022
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA), from Bristol Myers Squibb
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Feb 2022
Advanced Oxygen Therapy: Announcing Key Leadership Team Additions and Scientific Clinical Advisory Board Formation
Devices Wound Care Personnel

HSMN NewsFeed - 14 Feb 2022
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Feb 2022
Medtronic announces first procedure in Europe with Hugo(TM) robotic-assisted surgery system
Devices Surgery

HSMN NewsFeed - 26 Jan 2022
Smith & Nephew expands next-generation handheld robotic-assisted CORI(TM) Surgical System into total hip arthroplasty with RI.HIP NAVIGATION
Devices Orthopaedic

HSMN NewsFeed - 11 Jan 2022
ACELYRIN Appoints Melanie Gloria as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jan 2022
BlueWind Medical(TM) Ltd. Makes Key Additions to Leadership Team
Devices Urology Personnel

HSMN NewsFeed - 6 Jan 2022
New Procedure to Revolutionise Paediatric Ear Surgery Performed for the First Time with AventaMed Solo + Tympanostomy Tube Device (TTD)
Devices

HSMN NewsFeed - 15 Dec 2021
ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features
Devices Oncology FDA

HSMN NewsFeed - 14 Dec 2021
Medtronic INVOS(TM) 7100 Cerebral/Somatic Oximetry System receives 510(k) clearance for pediatric indications
Devices Monitoring FDA

HSMN NewsFeed - 6 Dec 2021
Sapience Therapeutics Receives FDA Fast Track Designation for ST101 for the Treatment of Recurrent Glioblastoma Multiforme (GBM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 6 Dec 2021
Biohaven Names CEO Vlad Coric, MD, Chairman Of The Board Of Directors And Matthew Buten, Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Nov 2021
Priothera Appoints Elisabeth Kueenburg M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Nov 2021
ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide
Devices Oncology

HSMN NewsFeed - 23 Nov 2021
Smith & Nephew Launches 'Turn-Key' Robotic-Assisted Surgical System; Designed to Quickly Augment the Orthopaedic Team's Skills Set for Greater Accuracy(1-3)�, Improved Outcomes(4), and Potentially an Immediate Scalable Solution to NHS
Devices Orthopaedic Surgery Product Launch

HSMN NewsFeed - 17 Nov 2021
NURTEC(R) ODT Approved In Kuwait For Acute Treatment Of Migraine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Nov 2021
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
Devices Personnel

HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 2 Nov 2021
Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense(TM) Data in Rune's Software for Precision Neurology
Devices Neurology

HSMN NewsFeed - 25 Oct 2021
Helsinki University Hospital Selects MRIdian(R) System for Installation at Comprehensive Cancer Center
Devices Oncology

HSMN NewsFeed - 21 Oct 2021
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
Devices Personnel

HSMN NewsFeed - 20 Oct 2021
Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Oct 2021
Medtronic Hugo(TM) Robotic-Assisted Surgery System Receives European CE Mark Approval
Devices Surgery Regulatory

HSMN NewsFeed - 7 Oct 2021
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 Sep 2021
Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies
Devices Orthopaedic Neurosurgery Product Launch

HSMN NewsFeed - 30 Sep 2021
OLUMIANT(R) Significantly Improved Hair Regrowth to At Least 80% Scalp Coverage as Early as 24 Weeks Across First Completed Phase 3 Studies for Alopecia Areata
Biopharmaceuticals

HSMN NewsFeed - 28 Sep 2021
Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
Devices Interventional Regulatory

HSMN NewsFeed - 27 Sep 2021
First Procedure in Asia-Pacific Performed with Medtronic Hugo(TM) Robotic-Assisted Surgery System
Devices Surgery

HSMN NewsFeed - 21 Sep 2021
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 9 Sep 2021
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Sep 2021
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
Devices Cardiology Personnel

HSMN NewsFeed - 1 Sep 2021
Smith & Nephew to expand Real Intelligence digital ecosystem and CORI(TM) Surgical System with total hip arthroplasty
Devices Orthopaedic

HSMN NewsFeed - 27 Aug 2021
Real-World Data Demonstrate Significant Reduction in Complications and Reinterventions with Medtronic Micra Leadless Pacemaker
Devices Interventional Cardiology

HSMN NewsFeed - 24 Aug 2021
European Commission Approves RINVOQ(R) (upadacitinib) as First JAK Inhibitor in the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 20 Aug 2021
Cardiac Dimensions(R) Announces Launch of Its Optimized U.S. Pivotal Trial - The EMPOWER Trial
Devices Interventional Cardiology

HSMN NewsFeed - 19 Aug 2021
Stryker Heads To Truist Field To Educate Charlotte Knights Fans On Mako SmartRobotics(TM) Technology
Devices Orthopaedic

HSMN NewsFeed - 18 Aug 2021
Zimmer Biomet Receives FDA Clearance for ROSA(R) Hip System for Robotically-Assisted Direct Anterior Total Hip Arthroplasty
Devices Orthopaedic FDA

HSMN NewsFeed - 17 Aug 2021
Smith & Nephew expands its leading WEREWOLF(TM) Technology into total joint arthroplasty with launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand
Devices Orthopaedic Surgery Product Launch

HSMN NewsFeed - 6 Aug 2021
Medtronic to Acquire Intersect ENT
Devices Mergers & Acquisitions

HSMN NewsFeed - 3 Aug 2021
SynOx Therapeutics Further Strengthens Team with Appointments of Chief Medical Officer and Chief Technology Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 Aug 2021
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 28 Jul 2021
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
Devices Cardiology FDA

HSMN NewsFeed - 27 Jul 2021
SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Jul 2021
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 21 Jul 2021
FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
Devices FDA

HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Jul 2021
Targovax ASA appoints Dr Lone Ottesen as Chief Development Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Jun 2021
Palatin Announces New Additions to Its Senior Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2021
Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jun 2021
BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Jun 2021
First Procedure in the World with Medtronic Hugo(TM) Robotic-Assisted Surgery System Performed at Cl�nica Santa Maria in Chile
Devices Surgery

HSMN NewsFeed - 18 Jun 2021
deCODE genetics: Predicting the probability of death
Diagnostics

HSMN NewsFeed - 14 Jun 2021
Jim Vasselli, M.D., Joins Aulos Bioscience as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Jun 2021
Cardinal Health(TM) Nuclear & Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK(R) Pediatric Indication
Biopharmaceuticals Radiology Oncology FDA

HSMN NewsFeed - 7 Jun 2021
FDA Approves First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy
Devices Neurology FDA

HSMN NewsFeed - 7 Jun 2021
Zimmer Biomet Announces New Appointments to Executive Leadership Team
Devices Orthopaedic Personnel

HSMN NewsFeed - 3 Jun 2021
Medtronic Gains FDA Clearance of UNiD(TM) Patient-Specific Rods for Use with CD Horizon(TM) Solera(TM) Voyager(TM) and Infinity(TM) OCT Spinal Systems
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 3 Jun 2021
Medtronic to Stop Distribution and Sale of HVAD(TM) System
Devices Cardiology Distribution

HSMN NewsFeed - 26 May 2021
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
Devices Drug Delivery Endocrinology Regulatory

HSMN NewsFeed - 18 May 2021
Late Breaking Data at EuroPCR Demonstrates Long-Term Benefits of Medtronic Radiofrequency Renal Denervation in Real-World Hypertensive Patients
Devices Interventional Cardiology

HSMN NewsFeed - 10 May 2021
Medtronic Launches New Pediatric Monitor That Alerts Clinicians to Potential Airway Obstructions During Ventilation
Devices Monitoring Product Launch

HSMN NewsFeed - 6 May 2021
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
Devices Endocrinology Acquisitions

HSMN NewsFeed - 5 May 2021
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 4 May 2021
Astellas' XTANDI(TM) (enzalutamide) Approved by European Commission for Men with Metastatic Hormone-Sensitive Prostate Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 3 May 2021
Medtronic Announces CE Mark of Evolut(TM) PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 30 Apr 2021
Smith & Nephew sponsored research shows COVID-19 has accelerated patient involvement in chronic wound care which can be supported by advanced foams such as ALLEVYN(TM) LIFE Dressing
Devices Wound Care

HSMN NewsFeed - 28 Apr 2021
Computer-guided surgery with Smith & Nephew's hip replacement implants shown to significantly improve survivorship and increase patient satisfaction compared to conventional surgery
Devices Orthopaedic

HSMN NewsFeed - 27 Apr 2021
Medtronic Receives FDA Breakthrough Designation for the Emprint(TM) Ablation Catheter Kit
Devices FDA

HSMN NewsFeed - 27 Apr 2021
Medtronic Receives FDA Approval to Launch Clinical Study for Implantable Tibial Neuromodulation Therapy for Bladder Incontinence
Devices Urology FDA

HSMN NewsFeed - 26 Apr 2021
Medtronic Partners with Surgical Theater to Provide First Augmented Reality Platform for Use in Real-Time During Complex Cranial Procedures
Devices Neurosurgery

HSMN NewsFeed - 21 Apr 2021
Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)
Devices Interventional FDA

HSMN NewsFeed - 20 Apr 2021
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Biopharmaceuticals

HSMN NewsFeed - 14 Apr 2021
Medtronic Announces European Launch of World's First Infusion Set with Wear up to Seven Days to Help Reduce Burden for People with Diabetes
Devices Drug Delivery Product Launch

HSMN NewsFeed - 12 Apr 2021
U.S. FDA Grants De Novo Clearance for First and Only Artificial Intelligence System for Colonoscopy; Medtronic Launches GI Genius(TM) Intelligent Endoscopy Module
Devices Gastroenterology FDA Product Launch

HSMN NewsFeed - 2 Apr 2021
S4 Medical Closes Series A Financing
Devices Cardiology Venture Capital

HSMN NewsFeed - 30 Mar 2021
PTC Therapeutics Announces the European Approval of Evrysdi(TM) for the Treatment of Spinal Muscular Atrophy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Mar 2021
Medtronic Receives CE Mark Approval for SenSight(TM) Directional Lead System for DBS Therapy
Devices Neurology Regulatory

HSMN NewsFeed - 18 Mar 2021
Boston Scientific Receives FDA Approval for TheraSphere(TM) Y-90 Glass Microspheres
Devices Oncology FDA

HSMN NewsFeed - 15 Mar 2021
ViewRay Announces Departure of Chief Operating Officer
Devices Personnel

HSMN NewsFeed - 11 Mar 2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Feb 2021
Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim(TM) SureScan(TM) MRI Leads
Devices Neurology FDA

HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 Feb 2021
Medtronic Announces Voluntary Recall of Unused Valiant Navion(TM) Thoracic Stent Graft System
Devices Product Recall

HSMN NewsFeed - 11 Feb 2021
Penn State Health Purchases Second ViewRay MRIdian(R) Linac
Devices Radiology Oncology

HSMN NewsFeed - 2 Feb 2021
OncoSec Strengthens Management Team With Two New Appointments
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Jan 2021
Smith & Nephew's PICO(TM) Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications
Devices Surgery Wound Care

HSMN NewsFeed - 26 Jan 2021
The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian(R) Linac
Devices Oncology

HSMN NewsFeed - 6 Jan 2021
Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 5 Jan 2021
Sebela Pharmaceuticals Announces U.S. Launch of SUTAB(R) Tablets, An Alternative to Liquid Colonoscopy Preparation
Biopharmaceuticals Gastroenterology FDA Product Launch

HSMN NewsFeed - 31 Dec 2020
ImmVira Announces Series C Financing with Leading Specialist Investors
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 29 Dec 2020
AIVITA Biomedical Closes $25 Million Financing Round
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 28 Dec 2020
Elevar Therapeutics Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea(R) (Paclitaxel Micellar) in Europe
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 21 Dec 2020
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Dec 2020
Nuvo Pharmaceuticals(R) Announces Corporate Rebranding as Miravo Healthcare(TM)
Biopharmaceuticals

HSMN NewsFeed - 16 Dec 2020
Medtronic Strengthens Leadership in Navigated, Robotic Spine Surgery with FDA Clearance of Midas Rex(TM) Drills and Navigated Disc Prep and Interbodies for U.S. with Mazor(TM) Robotic Guidance System
Devices FDA

HSMN NewsFeed - 16 Dec 2020
New data confirms Smith & Nephew technology as the best performing cementless construct for Total Hip Arthroplasty�
Devices Orthopaedic

HSMN NewsFeed - 15 Dec 2020
Medtronic's OsteoCool(TM) Procedure Shows Significant, Swift Pain Relief and Sustained Improvement for Cancer Patients
Devices Interventional Oncology

HSMN NewsFeed - 11 Dec 2020
CHMP Recommends the Approvals of RINVOQ(TM) (Upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis and Ankylosing Spondylitis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Biopharmaceutical Personnel

HSMN NewsFeed - 18 Nov 2020
Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 16 Nov 2020
Medtronic Completes Acquisition of Medicrea
Devices Orthopaedic Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 12 Nov 2020
Medtronic Launches InPen(TM) with Real-Time Guardian(TM) Connect CGM Data -- the First Integrated Smart Insulin Pen for People with Diabetes on MDI
Devices Drug Delivery Endocrinology Product Launch

HSMN NewsFeed - 12 Nov 2020
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 10 Nov 2020
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Nov 2020
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
Biopharmaceutical Drug Delivery Personnel

HSMN NewsFeed - 6 Nov 2020
BioElectronics' ActiPatch(R) Therapy To Be Marketed By DonJoy(R) Advantage
Devices Orthopaedic Distribution

HSMN NewsFeed - 5 Nov 2020
Endo Announces Strategic Actions to Further Position the Company for Long-Term Success
Biopharmaceuticals

HSMN NewsFeed - 3 Nov 2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
Devices Oncology Personnel

HSMN NewsFeed - 29 Oct 2020
Medtronic Expands ENT Portfolio with FDA Clearance of NIM Vital(TM) Next Generation Intraoperative Nerve Monitoring System and Acquisiton of Ai Biomed Corp.
Devices Neurology FDA Mergers & Acquisitions

HSMN NewsFeed - 26 Oct 2020
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program
Biopharmaceuticals Licensing Acquisitions

HSMN NewsFeed - 19 Oct 2020
BioSpecifics to be Acquired by Endo Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Oct 2020
Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut(TM) TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients
Devices Interventional Cardiology

HSMN NewsFeed - 14 Oct 2020
Louis Stokes Cleveland VA Medical Center Purchases ViewRay's MRIdian Linac for MRI-Guided Radiation Therapy
Devices Oncology

HSMN NewsFeed - 12 Oct 2020
OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Oct 2020
Priothera closes �30 million Series A financing to develop highly promising therapies for acute myeloid leukemia (AML)
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 6 Oct 2020
Medtronic Announces First Patient Implanted in ELITE Study of InterStim(TM) Micro
Devices Urology

HSMN NewsFeed - 30 Sep 2020
Medtronic to Acquire Avenu Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 23 Sep 2020
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
Biopharmaceuticals

HSMN NewsFeed - 18 Sep 2020
CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 16 Sep 2020
Medtronic TYRX(TM) Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections
Devices Cardiology

HSMN NewsFeed - 10 Sep 2020
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
Devices Monitoring

HSMN NewsFeed - 1 Sep 2020
Olive Diagnostics exits Stealth Mode; delivers world's first consumer-use, hands-free, urinalysis solution
Diagnostics

HSMN NewsFeed - 1 Sep 2020
10,000th Patient Receives Treatment with ViewRay's MRIdian System
Devices Radiology Oncology

HSMN NewsFeed - 13 Aug 2020
Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay's MRIdian Linac
Devices Radiology Oncology

HSMN NewsFeed - 23 Jul 2020
Quadriga BioSciences Initiates Clinical Trial of Innovative, Targeted Treatment for Brain Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Jul 2020
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 10 Jul 2020
Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study
Biopharmaceuticals

HSMN NewsFeed - 30 Jun 2020
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 25 Jun 2020
Long-Term Results from SABR-COMET Further Demonstrate Effectiveness of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Metastatic Cancers
Devices Oncology

HSMN NewsFeed - 23 Jun 2020
Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Jun 2020
Smith & Nephew announces new milestone with its OXINIUM(TM) Advanced Bearing System implants surpassing two million procedures
Devices Orthopaedic

HSMN NewsFeed - 3 Jun 2020
New publication shows Smith & Nephew's OXINIUM(TM) (Oxidized Zirconium) on XLPE for total hip arthroplasty as best performing bearing beyond 10 years
Devices Orthopaedic

HSMN NewsFeed - 29 May 2020
XTANDI(R) (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 27 May 2020
Providence Portland Medical Center Begins Patient Treatments with ViewRay's MRIdian Linac
Devices Oncology

HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 May 2020
Centerline Biomedical Appoints Key Physician Thought Leaders and Executives as Advisors
Devices Surgery Personnel

HSMN NewsFeed - 22 May 2020
Hikma receives FDA approval for its generic Vascepa(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 20 May 2020
Smith & Nephew launches new JOURNEY(TM) II Unicompartmental Knee System
Devices Orthopaedic Product Launch

HSMN NewsFeed - 11 May 2020
Jazz Pharmaceuticals Announces Appointment Of Kim Sablich As Executive Vice President, General Manager Of North America
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2020
Galderma Receives FDA Approval For Restylane(R) Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
Devices Dermatology FDA

HSMN NewsFeed - 1 May 2020
SciBase Receives FDA Approval for Nevisense 3.0
Devices Dermatology Oncology FDA

HSMN NewsFeed - 30 Apr 2020
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Apr 2020
R2 Technologies Receives $10M Second Tranche Investment for Landmark CryoAesthetic Technology
Devices Dermatology Venture Capital

HSMN NewsFeed - 21 Apr 2020
IDEAYA Biosciences Announces Addition of Julie Patel as Vice President, Human Resources, Enhancing its Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Apr 2020
Biocept Launches Unique Line of Molecular Assay Kits for Detection of Key Oncogene Mutations Based on its Proprietary Target Selector(TM) Technology Validated for Use in Both Tissue and Blood Samples
Diagnostics Oncology Product Launch

HSMN NewsFeed - 15 Apr 2020
Synapse Biomedical Receives FDA Emergency Use Authorization for New System to Assist in Weaning Patients off of Ventilators During COVID-19 Pandemic
Devices FDA

HSMN NewsFeed - 15 Apr 2020
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Apr 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Mar 2020
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
Diagnostics Regulatory

HSMN NewsFeed - 25 Mar 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 24 Mar 2020
Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 16 Mar 2020
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Mar 2020
ADVANZ PHARMA to Acquire Correvio
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Mar 2020
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Mar 2020
AbbVie Receives European Commission Approval of VENCLYXTO(R) Combination Regimen for Patients with Previously-Untreated Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 3 Mar 2020
Smith & Nephew Announces US Launch of Pico(TM) 14 Single Use Negative Pressure Wound Therapy System for Use On High Risk Surgical Patients
Devices Wound Care Product Launch

HSMN NewsFeed - 19 Feb 2020
Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
Devices Monitoring Drug Delivery Endocrinology

HSMN NewsFeed - 14 Feb 2020
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
Diagnostics Oncology Personnel

HSMN NewsFeed - 7 Feb 2020
Elios Therapeutics Presents New Phase IIb Data for Personalized Cancer Vaccine in High-Risk Melanoma Patients at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Jan 2020
Astanza Laser Wins Marketing/PR Campaign Of The Year, Training Support Of The Year, And Customer Service Of The Year Awards At The 2019 MyFaceMyBody Global Aesthetic Awards
Devices Dermatology

HSMN NewsFeed - 17 Jan 2020
SkinMedica(R) Launches New Instant Bright Eye Cream For Immediate, Visible Results
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 13 Jan 2020
Bardy Diagnostics(TM) Names Ed Vertatschitsch as Chief Operating Officer and Announces Additions to the Leadership Team
Devices Monitoring Cardiology Personnel

HSMN NewsFeed - 19 Dec 2019
Michigan Community Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
Devices Oncology

HSMN NewsFeed - 12 Dec 2019
European Commission Approves EVENITY(R) (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Nov 2019
Alkermes Completes Acquisition of Rodin Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 21 Nov 2019
Biocept Announces the Launch of its Liquid Biopsy Test to Detect TRK Biomarkers in the Blood of Patients Diagnosed with Cancer
Diagnostics Oncology Product Launch

HSMN NewsFeed - 20 Nov 2019
First Cryoballoon Ablation Procedures Performed Using the VersaCross(R) Transseptal Solution
Devices Interventional Cardiology

HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Biopharmaceuticals Dermatology

HSMN NewsFeed - 15 Nov 2019
Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Nov 2019
Allergan Receives FDA Qualified Infectious Disease Product (QIDP) Designation And Fast Track Designation For ATM-AVI (Aztreonam And Avibactam) For Antibiotic-Resistant Gram-Negative Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Nov 2019
Janssen Announces Submission of Supplemental New Drug Application to U.S. FDA Seeking Approval of IMBRUVICA(R) (ibrutinib) in Combination with Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 7 Nov 2019
Biocept Announces CE IVD Marks and Availability of its CEE-Sure(R) Blood Collection Tube and Sample Collection Shipping Kit in Europe
Diagnostics Oncology Regulatory Product Launch

HSMN NewsFeed - 5 Nov 2019
Regeneron Provides Updates on Phase 3 Libtayo(R) (cemiplimab) Development Program in Advanced Non-small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 28 Oct 2019
Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation
Biopharmaceuticals Dermatology

HSMN NewsFeed - 25 Oct 2019
European Commission Approves Astellas' XOSPATA(TM) (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 24 Oct 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Oct 2019
European Symposium to Advance Adoption of MRI-Guided Radiation Therapy
Devices Radiology Oncology

HSMN NewsFeed - 18 Oct 2019
AbbVie Receives CHMP Positive Opinion for Upadacitinib (RINVOQ(TM)) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Oct 2019
Patient Treatments with ViewRay's MRIdian Linac Begin in New England
Devices Oncology

HSMN NewsFeed - 30 Sep 2019
Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 25 Sep 2019
Body Vision Closing $20 Million in Series C Funding
Devices Diagnostics Venture Capital

HSMN NewsFeed - 13 Sep 2019
Abbott's Revolutionary FreeStyle(R) Libre System Now Reimbursed in the Two Largest Provinces in Canada
Devices Monitoring Endocrinology Reimbursement

HSMN NewsFeed - 13 Sep 2019
Alkermes Announces the Appointment of Richard Gaynor, M.D. and Andy Wilson to its Board of Directors and the Retirement of Director Floyd Bloom, M.D.
Biopharmaceuticals Oncology Neurology Personnel

HSMN NewsFeed - 12 Sep 2019
REDUCE FMR Study Shows Cardiac Dimensions' Carillon(R) System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure
Devices Interventional Cardiology

HSMN NewsFeed - 9 Sep 2019
DePuy Synthes Expands ATTUNE Knee Platform with Cementless Option
Devices Orthopaedic Product Launch

HSMN NewsFeed - 3 Sep 2019
Dynacure Appoints David Garrett as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juv�derm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Biopharmaceuticals Devices Dermatology FDA

HSMN NewsFeed - 3 Sep 2019
Endo Launches Authorized Generic Version of Noxafil(R) (posaconazole) Delayed-release Tablets in the United States
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 2 Sep 2019
Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki
Biopharmaceuticals Drug Delivery Oncology Acquisitions

HSMN NewsFeed - 30 Aug 2019
Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 29 Aug 2019
Heska Corporation Names Chief Operating Officer to Drive Expansion
Diagnostics Veterinary Personnel

HSMN NewsFeed - 27 Aug 2019
PIONYR Immunotherapeutics Announces Key Leadership Team Addition and Clinical Candidates Targeting Tumor-Associated Macrophages
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Aug 2019
Priya Chaturvedi, Ph.D., Appointed Vice President of Global Clinical Quality Assurance at Eisai Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Aug 2019
ViewRay Announces Results of the First Prospective Clinical Trial on MR-guided Radiation Treatment for Prostate Cancer Without Implanted Markers
Devices Oncology

HSMN NewsFeed - 12 Aug 2019
Shimadzu Medical Systems receives FDA 510(k) for the FLUOROspeed X1 RF system
Devices Radiology FDA

HSMN NewsFeed - 2 Aug 2019
Endo Applauds U.S. District Court Decision that Vasopressin Cannot be Used for Compounding by Outsourcing Facilities
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 1 Aug 2019
Endo Appoints Domenico Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Aug 2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo(R) (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jul 2019
Neuronetics(R) Launches TrakStar(R) Plus Patient Data Management System to Maximize Physician Time with Patients
Devices Neurology Product Launch

HSMN NewsFeed - 24 Jul 2019
Allergan Voluntarily Recalls BIOCELL(R) Textured Breast Implants and Tissue Expanders
Devices Product Recall

HSMN NewsFeed - 17 Jul 2019
U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 17 Jul 2019
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 15 Jul 2019
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Jul 2019
IDEAYA Biosciences Strengthens Management with Internal Appointments of Paul Stone, J.D., as Chief Financial Officer, Andres Ruiz Briseno, C.P.A., as Vice President, Finance, and Mick O'Quigley, M.B.A, as Vice President, Development Operations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 25 Jun 2019
AbbVie to Acquire Allergan in Transformative Move for Both Companies
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jun 2019
Allergan Receives FDA Clearance For CoolTone(TM) Device
Devices Dermatology FDA

HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Jun 2019
Pfizer to Acquire Array BioPharma
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Jun 2019
Medical Fish Skin Company Kerecis Limited Completes $16 Million Series C Offering
Regenerative Medicine Wound Care Venture Capital

HSMN NewsFeed - 11 Jun 2019
Thommen Medical USA Announces Leadership Changes To Drive New Market Position
Devices Dental Personnel

HSMN NewsFeed - 7 Jun 2019
Study Published in Journal of Clinical Investigation Insight Demonstrates Ability to Predict Early Rejection in Kidney Transplant with FractalDx Portfolio Technology
Diagnostics

HSMN NewsFeed - 6 Jun 2019
Palatin Technologies Granted FDA Orphan Drug Designation -- PL-8177 for the Treatment of Non-Infectious Uveitis
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 5 Jun 2019
FDA Premarket Approval Granted for DT MedTech's Hintermann Series H3(TM) Total Ankle Replacement System
Devices Orthopaedic FDA

HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 May 2019
Rani Therapeutics Hires First CFO
Devices Drug Delivery Personnel

HSMN NewsFeed - 9 May 2019
MiMedx Appoints Timothy R. Wright as Chief Executive Officer
Devices Wound Care Personnel

HSMN NewsFeed - 8 May 2019
Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier
Devices Oncology Dermatology Group Purchasing

HSMN NewsFeed - 6 May 2019
Heska Corporation Names Chief Financial Officer to Enhance Executive Team
Biopharmaceuticals Diagnostics Veterinary Personnel

HSMN NewsFeed - 26 Apr 2019
Aratana Therapeutics to be Acquired by Elanco Animal Health
Biopharmaceuticals Veterinary Mergers & Acquisitions

HSMN NewsFeed - 24 Apr 2019
Xstrahl Spotlights Full Range of X-Ray Therapy and Radiation Research Systems at ESTRO 2019
Devices Oncology

HSMN NewsFeed - 22 Apr 2019
Neurelis Announces Completion of Senior Management Team Buildout to Support the Anticipated Commercial Launch of VALTOCO(TM)
Biopharmaceuticals Drug Delivery Neurology Personnel

HSMN NewsFeed - 18 Apr 2019
ViewRay Partners with Leading Canadian Distributor to Bring MRI-guided Radiation Therapy to Canada
Devices Radiology Oncology Distribution

HSMN NewsFeed - 17 Apr 2019
ViewRay Partners with Largest Independent Distributor in Australia and New Zealand to Bring Benefits of MRI-Guided Radiation Therapy to the Region
Devices Oncology Distribution

HSMN NewsFeed - 10 Apr 2019
OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12
Biopharmaceuticals Oncology Drug Delivery

HSMN NewsFeed - 9 Apr 2019
FDA Clears VITROS(R) XT Chemistry Product Slides from Ortho Clinical Diagnostics
Diagnostics FDA

HSMN NewsFeed - 9 Apr 2019
Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA(R) and INVEGA SUSTENNA(R) for the Treatment of Schizophrenia
Biopharmaceuticals

HSMN NewsFeed - 5 Apr 2019
Endo Begins Shipment of Authorized Generic Version of PROVENTIL(R) (albuterol sulfate) HFA Inhalation Aerosol in the United States
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 1 Apr 2019
OncoSec Announces Advanced Therapy Medicinal Product Classification from the EMA for TAVO(TM) in Refractory Metastatic Melanoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 1 Apr 2019
Audentes Therapeutics Appoints Legal and Corporate Communications Executives; Promotes Thomas P. Soloway to Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Mar 2019
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA(R)
Biopharmaceuticals Generics Dermatology

HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Mar 2019
IRRAS Strengthens Executive Team With Addition of Dr. Vinny Podichetty as Vice President of Clinical Affairs
Devices Neurosurgery Personnel

HSMN NewsFeed - 8 Mar 2019
Positive Interim Analysis in Pivotal IsoConDa Phase III Study
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Mar 2019
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Mar 2019
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI(TM)) for the Treatment of Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 25 Feb 2019
FDA Approves Taiho Oncology's LONSURF(R) (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 21 Feb 2019
ViewRay Announces FDA 510(k) Clearance for Advancements in MRI and Functional Imaging Technologies for MRIdian MRI-Guided Radiation Therapy System
Devices Oncology Radiology FDA

HSMN NewsFeed - 20 Feb 2019
Hygieia Receives 510(k) Clearance from FDA for Phone App That Enhances Company's d-Nav Insulin Guidance Service
Devices Endocrinology FDA

HSMN NewsFeed - 28 Jan 2019
Biocept Launches Liquid Biopsy Kits Intended to Broaden Use of its Proprietary Technology Platform for High Sensitivity Detection of Circulating Tumor DNA
Diagnostics Oncology Product Launch

HSMN NewsFeed - 28 Jan 2019
U.S. FDA Approves IMBRUVICA(R) (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Na�ve Patients with Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 22 Jan 2019
European Commission Approves BLINCYTO(R) (blinatumomab) In Patients With Philadelphia Chromosome Negative Minimal Residual Disease-Positive B-cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 22 Jan 2019
World's First MRIdian Center Celebrates Five Years of MRI-Guided Radiation Treatments
Devices Oncology

HSMN NewsFeed - 17 Jan 2019
Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention
Devices Cardiology Monitoring

HSMN NewsFeed - 4 Jan 2019
ViewRay Announces First Patient Enrolled in Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) Trial for Locally Advanced Pancreatic Cancer
Devices Oncology

HSMN NewsFeed - 4 Jan 2019
Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF Alpha Antibody Fragment
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 4 Jan 2019
Oculis Raises CHF15.5 Million in an Extension of its Series B Financing Round - Total Raised CHF35.5 Million
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 21 Dec 2018
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
Biopharmaceuticals Cardiology

HSMN NewsFeed - 20 Dec 2018
Kypha Secures $4M Series A Funding to Accelerate First-in-Class Diagnostic Platform Commercialization
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Dec 2018
HeartGuide, the highly-anticipated first wearable blood pressure monitor from Omron, available for pre-order on December 20th
Devices Monitoring Product Launch

HSMN NewsFeed - 17 Dec 2018
PharmaEssentia and AOP Orphan Receive Positive CHMP Opinion For Besremi(TM) (Ropeginterferon alfa-2b) For Treatment Of Polycythemia Vera (PV) In EU
Biopharmaceuticals Regulatory

HSMN NewsFeed - 13 Dec 2018
FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Dec 2018
Perrigo Announces the Launch of an AB Rated Generic Version of Topicort(R) Topical Spray 0.25%
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 29 Nov 2018
Nuvo Pharmaceuticals(TM) Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 27 Nov 2018
Perrigo Launches Its AB Rated Generic Version of Solaraze(R) Gel 3%
Biopharmaceuticals Generics Dermatology Product Launch

HSMN NewsFeed - 26 Nov 2018
Perrigo Announces Tentative FDA Approval For The First To File Generic Version Of Ultravate(R) Lotion 0.05%
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Nov 2018
Allergan Makes New Appointments to Finance Leadership Team
Biopharmaceuticals Ophthalmology Dermatology Personnel

HSMN NewsFeed - 21 Nov 2018
Rob Fuchs joins ViewRay as Chief Human Resources Officer
Devices Oncology Personnel

HSMN NewsFeed - 20 Nov 2018
OrthoXel(TM) Orthopaedic Trauma Device Company Announce CE Mark Clearance Following FDA 510(k) for new Apex Femoral Nailing System
Devices Orthopaedic Regulatory

HSMN NewsFeed - 20 Nov 2018
Oculis Strengthens its Global Clinical and Business Development Capabilities Through Strategic Appointments to Senior Management Team
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Nov 2018
STERIBITE(R) Announces FDA Clearance of the Steribite Disposable Kerrison Rongeur
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 13 Nov 2018
NeuroStar(R) Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment
Devices Neurology Distribution

HSMN NewsFeed - 8 Nov 2018
Sutro Appoints Industry Veteran Shalini Sharp to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Nov 2018
Biocept Announces New Executive Hires to its Sales and Marketing Organization
Diagnostics Oncology Personnel

HSMN NewsFeed - 2 Nov 2018
TempTraq(R) Wearable Temperature Monitoring Patch Earns CE Mark Approval
Devices Monitoring Regulatory

HSMN NewsFeed - 2 Nov 2018
Torque Announces Appointment of Immunotherapy Pioneer F. Stephen Hodi, MD, to Scientific Advisory Board and Alex Bruni as COO/ CFO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Nov 2018
AbbVie Receives European Commission Approval of VENCLYXTO(R) (venetoclax) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 29 Oct 2018
Perrigo Confirms Patent Challenge For Generic Version Of Kerydin(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 Oct 2018
OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Oct 2018
Perrigo Confirms Patent Challenge For Generic Version Of Narcan(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Biopharmaceuticals Dermatology Acquisitions

HSMN NewsFeed - 24 Oct 2018
FDA Approves New SynchroMed(TM) II myPTM(TM) Personal Therapy Manager That Enables Patients to Alleviate Unpredictable Pain
Devices Drug Delivery Neurology FDA

HSMN NewsFeed - 17 Oct 2018
AbbVie Announces Supplemental New Drug Application Accepted for Priority Review by U.S. FDA for IMBRUVICA(R) (ibrutinib) in Combination with Obinutuzumab (GAZYVA(R)) for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 16 Oct 2018
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 15 Oct 2018
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301 for the Treatment of Cutaneous T-cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Oct 2018
Bausch Health's BRYHALI(TM) (halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 4 Oct 2018
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
Devices Dermatology FDA

HSMN NewsFeed - 2 Oct 2018
ViewRay Appoints Industry Veteran James Alecxih as Chief Commercial Officer
Devices Oncology Radiology Personnel

HSMN NewsFeed - 1 Oct 2018
Perrigo Confirms Patent Challenge for Generic Version of Jublia(R) Topical Solution 10%
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 24 Sep 2018
Oculis Appoints World-renowned Ophthalmology Specialist
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 19 Sep 2018
Oculis Elects Anthony Rosenberg and David A. Weber - Veterans of the Global Pharmaceutical and Eye-care Industries - to its Board of Directors
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 14 Sep 2018
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 10 Sep 2018
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 7 Sep 2018
Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Imodium(R) Multi-Symptom Relief
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 5 Sep 2018
Halozyme Names Benjamin Hickey As Chief Commercial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 Aug 2018
European Commission Approves BLINCYTO(R) (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 28 Aug 2018
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Devices Cardiology

HSMN NewsFeed - 28 Aug 2018
OncoSec Appoints Alain Algazi, MD, as Clinical Strategic Advisor
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Aug 2018
Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA(R) (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice
Biopharmaceuticals

HSMN NewsFeed - 27 Aug 2018
AbbVie Announces IMBRUVICA(R) (ibrutinib) Plus Rituximab Approval by U.S. FDA as First Chemotherapy-Free Combination Treatment in Adults with Waldenstr�m's Macroglobulinemia, a Rare Type of Blood Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 27 Aug 2018
Vyxeos(R) Receives Marketing Authorisation in the European Union for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 24 Aug 2018
Sotera Medical Secures Additional Funding
Devices Cardiology Venture Capital

HSMN NewsFeed - 23 Aug 2018
Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Aug 2018
Medtronic Announces Commercial Launch of the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon in Japan
Devices Interventional Product Launch

HSMN NewsFeed - 15 Aug 2018
Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 13 Aug 2018
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA(R) (edoxaban)
Biopharmaceuticals

HSMN NewsFeed - 10 Aug 2018
Nuvo Pharmaceuticals(TM) Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 9 Aug 2018
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex(R)
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Aug 2018
Perrigo Announces Plan To Separate Prescription Pharmaceuticals Business
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 8 Aug 2018
Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process
Biopharmaceuticals Ophthalmology Dermatology Personnel

HSMN NewsFeed - 8 Aug 2018
Apexigen Raises $73 Million In Series B And Series C Financings
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 7 Aug 2018
Array BioPharma Receives FDA Breakthrough Therapy Designation for BRAFTOVI(TM) in combination with MEKTOVI(R) and cetuximab for BRAFV600E-mutant Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 6 Aug 2018
AOBiome Therapeutics Announces the Expansion of its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Aug 2018
Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids
Devices Dermatology FDA Product Launch

HSMN NewsFeed - 2 Aug 2018
Endo Announces Appointment of Laure Park as Senior Vice President, Investor Relations and Corporate Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Aug 2018
IGM Biosciences Appoints Daniel S. Chen, M.D., Ph.D., as Chief Medical Officer; Names William Strohl, Ph.D., to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Aug 2018
BD Appoints Simon Campion to Interventional Segment President
Devices Interventional Personnel

HSMN NewsFeed - 30 Jul 2018
OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Jul 2018
Endo Begins Shipment of Authorized Generic Version of INVANZ(R) (ertapenem for injection) in the United States
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 23 Jul 2018
Allergan Receives FDA Fast Track Designation for AGN-241751 for the Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jul 2018
Olympus Appoints New Director of Medical and Surgical Business for the UK and Ireland
Devices Personnel

HSMN NewsFeed - 13 Jul 2018
Kypha Acquires Biosensia - Expands First-in-Class Immune Status Monitoring Platforms
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 13 Jul 2018
The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI(TM) (encorafenib) in Combination with MEKTOVI(R) (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Jul 2018
Polaris Announces Drs. James Allison and Padmanee Sharma Joining its Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Jul 2018
FDA Clears The Way: Lipogems' Receives FDA Clearance For Microfragmented Adipose Tissue System Utilizing Body's Own Fat To Support Tissue Repair In Orthopaedic And Arthroscopic Surgeries
Regenerative Medicine Orthopaedic FDA

HSMN NewsFeed - 5 Jul 2018
Boston Scientific to Acquire Cryterion Medical, Inc.
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 29 Jun 2018
Ultragenyx Announces Positive CHMP Opinion for Mepsevii(TM) (vestronidase alfa) For the Treatment of Mucopolysaccharidosis VII
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Jun 2018
Avella Selected by Array BioPharma Inc. to distribute BRAFTOVI(TM) (encorafenib) and MEKTOVI(R) (binimetinib)
Biopharmaceuticals Oncology Distribution

HSMN NewsFeed - 25 Jun 2018
IMBRUVICA(R) (ibrutinib) Supplemental New Drug Application Accepted for Review by U.S. FDA with Potential to Broaden Treatment Use as a Combination Treatment Option with Rituximab in Waldenstr�m's Macroglobulinemia (WM), A Rare Form of Blood Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 Jun 2018
Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
Devices Interventional Radiology Orthopaedic FDA

HSMN NewsFeed - 20 Jun 2018
AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
Regenerative Medicine Oncology FDA

HSMN NewsFeed - 18 Jun 2018
Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jun 2018
Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
Devices Interventional FDA

HSMN NewsFeed - 14 Jun 2018
Allergan Continues Active Board Refreshment Process
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jun 2018
Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Jun 2018
Elbit Systems' Surgeon-Centered Visualization Spin-Off, Beyeonics, Raises $11.5 Million
Devices Surgery Venture Capital

HSMN NewsFeed - 11 Jun 2018
IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Jun 2018
MiMedx Announces Executive to Lead its International Operations and Provides Update on Company's International Progress
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 7 Jun 2018
Egalet Appoints Industry Veteran John Varian to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jun 2018
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine(R) (sargramostim) for the Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 30 May 2018
Legend Announces FDA Clearance of IND Application on CAR-T Immuno-cell Therapy for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 29 May 2018
UCB Announces the Approval of CIMZIA(R) (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis, Representing an Important New Option for Patients in the U.S.
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 29 May 2018
ADAPT Pharma(R) Launches NARCANDirect.com
Biopharmaceuticals Product Launch

HSMN NewsFeed - 24 May 2018
IMBRUVICA(R) (ibrutinib) Plus GAZYVA(R) (obinutuzumab) Phase 3 iLLUMINATE Trial for First-Line Therapy of Chronic Lymphocytic Leukemia (CLL) Patients Met Primary Endpoint
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 May 2018
Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
Devices Oncology Mergers & Acquisitions

HSMN NewsFeed - 17 May 2018
ImaginAb Reconstitutes Scientific Advisory Board
Biopharmaceuticals Oncology Radiology Personnel

HSMN NewsFeed - 10 May 2018
Lilly Announces Agreement To Acquire ARMO BioSciences
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 8 May 2018
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
Devices Oncology Dermatology Personnel

HSMN NewsFeed - 30 Apr 2018
FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 27 Apr 2018
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia(R) (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Apr 2018
AcelRx receives positive CHMP opinion for DZUVEO(TM) for management of acute moderate to severe pain in medically monitored settings
Biopharmaceutical Drug Delivery Regulatory

HSMN NewsFeed - 26 Apr 2018
Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited
Biopharmaceuticals Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 23 Apr 2018
Surmodics Announces FDA Clearance of a New .018� Low-Profile PTA Balloon Dilation Catheter
Devices Interventional FDA

HSMN NewsFeed - 20 Apr 2018
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO(R) (fosnetupitant/ palonosetron) in the United States
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 Apr 2018
Women Treated with Hologic's NovaSure(R) Endometrial Ablation System in New Study Reported Higher Amenorrhea Rates than Those Treated with Minerva
Devices Interventional

HSMN NewsFeed - 18 Apr 2018
ViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy
Devices Oncology

HSMN NewsFeed - 18 Apr 2018
Medical Microinstruments S.p.A. Announces �20M in Series A Funding to Advance Its Robotic Platform for Microsurgery
Devices Surgery Venture Capital

HSMN NewsFeed - 11 Apr 2018
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 2 Apr 2018
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Apr 2018
Endo Agrees to Extend Temporary Stay of FDA Litigation
Biopharmaceuticals FDA Litigation

HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 23 Mar 2018
Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin(R)) For The Treatment Of Three Types Of Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Mar 2018
Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)
Biopharmaceuticals Diagnostics Oncology

HSMN NewsFeed - 12 Mar 2018
Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 8 Mar 2018
Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Mar 2018
Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Mucinex(R) DM Maximum Strength Extended Release Tablets
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 6 Mar 2018
Stryker Launches Next Generation Trident(R) II Acetabular System
Devices Orthopaedic Product Launch

HSMN NewsFeed - 2 Mar 2018
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
Biopharmaceuticals HIV/AIDS Product Launch

HSMN NewsFeed - 27 Feb 2018
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 26 Feb 2018
Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 26 Feb 2018
Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test to Predict Treatment Response in Metastatic Disease
Diagnostics Oncology Product Launch

HSMN NewsFeed - 26 Feb 2018
New Data Show Lilly's Trulicity(R) (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Feb 2018
Amgen Receives Positive Opinion Expanding Use Of XGEVA(R) (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 21 Feb 2018
Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
Devices Drug Delivery Product Launch

HSMN NewsFeed - 7 Feb 2018
Abbott's App for FreeStyle(R) Libre System Now Available in Europe for Both iPhone and Android
Devices Monitoring Endocrinology Product Launch

HSMN NewsFeed - 2 Feb 2018
FDA Approves AVYCAZ(R) (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Feb 2018
Partner Therapeutics (PTx) Acquires Leukine(R) from Sanofi
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 22 Jan 2018
Elanco Animal Health Announces U.S. Food and Drug Administration (FDA) Approval of Credelio(R) (lotilaner) to Treat and Protect Against Ticks and Fleas
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Jan 2018
Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST(R) for Prophylaxis of Hereditary Angioedema Attacks
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jan 2018
Sequence Bio appoints Dr. Michael S. Phillips as Chief Scientific Officer to lead genomic research and drug discovery projects
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jan 2018
Nuvo Pharmaceuticals (Ireland) Limited Acquires U.S. Product Rights to Resultz(R) from Piedmont Pharmaceuticals LLC
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 11 Jan 2018
New Study Shows Superiority of Intrathecal Baclofen Therapy (ITB Therapy(SM)) Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity
Devices Drug Delivery Neurology

HSMN NewsFeed - 8 Jan 2018
Perrigo Appoints Uwe R�hrhoff As President & Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2018
Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 3 Jan 2018
Recro Pharma Announces Key Executive Promotions to the Financial Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2018
Perrigo Announces Tentative FDA Approval For The Generic Version Of Prolensa(R) Ophthalmic Solution 0.07%
Biopharmaceuticals Generics Ophthalmology FDA

HSMN NewsFeed - 2 Jan 2018
Nuvo Pharmaceuticals Inc.(TM) Acquires Global ex-U.S. Product Rights and existing Royalty Streams to Resultz(R) from Piedmont Pharmaceuticals LLC
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Dec 2017
Novartis' combination therapy Tafinlar(R) + Mekinist(R) granted FDA Priority Review for the adjuvant treatment of stage III BRAF V600 mutation-positive melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Dec 2017
Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2017
Allergan Receives FDA Clearance For the CoolSculpting(R) Treatment To Improve Appearance Of Lax Tissue In The Double Chin
Devices Dermatology FDA

HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2017
OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 29 Nov 2017
Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board
Devices Personnel

HSMN NewsFeed - 27 Nov 2017
Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo(R) 32mg Extended Release Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 27 Nov 2017
Pharming Submits Supplemental Biologics License Application to FDA for RUCONEST(R) for Prophylaxis of Hereditary Angioedema Attacks
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Nov 2017
Amgen Launches The ENBREL Mini(TM) Single-Dose Prefilled Cartridge With AutoTouch(TM) Reusable Autoinjector That Is Ergonomically Designed For Patients
Biopharmaceuticals Devices Drug Delivery Product Launch

HSMN NewsFeed - 15 Nov 2017
Noden Pharma Announces FDA Approval of Tekturna(R) (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 14 Nov 2017
NewLink Genetics Appoints Eugene Kennedy, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 13 Nov 2017
Spruce Biosciences Appoints Camilla V. Simpson to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2017
Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 10 Nov 2017
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Nov 2017
Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate(R) (romiplostim) In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Nov 2017
Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 3 Nov 2017
ViewRay's MRIdian Linac Selected as MR-Guided Radiotherapy System in Danish Tender
Devices Oncology

HSMN NewsFeed - 2 Nov 2017
Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato(R) Gel 0.05%
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Oct 2017
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
Biopharmaceuticals Generics Dermatology Litigation

HSMN NewsFeed - 25 Oct 2017
Sobi: Alprolix(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia B
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Oct 2017
OncoSec Presents Positive Phase 2 Data for ImmunoPulse(R) IL-12 in Combination with Pembrolizumab Demonstrating a Best Overall Response Rate (BORR) of 50% in Predicted Anti-PD-1 Non-Responder Melanoma Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Oct 2017
Amneal And Impax To Combine
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 10 Oct 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Oct 2017
Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 29 Sep 2017
Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Sep 2017
Perrigo Announces First-To-Market Launch of the OTC Store Brand Equivalent Of Nexium(R) 24HR Capsules
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 25 Sep 2017
EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology
Biopharmaceuticals Personalized Medicine Oncology

HSMN NewsFeed - 25 Sep 2017
Allergan Announces Tessa Hilado, Executive Vice President and Chief Financial Officer, to Retire from Company
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 15 Sep 2017
Myriad Genetics Announces Positive Data Supporting New riskScore(TM) Test at the 36th Annual Conference of the National Society of Genetic Counselors
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 15 Sep 2017
NCCN Guidelines to Include Categories of Preference
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 13 Sep 2017
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 12 Sep 2017
Vasorum Launches Celt ACD(R) Second Generation Vascular Closure Device in the USA
Devices Interventional Product Launch

HSMN NewsFeed - 8 Sep 2017
Regeneron and Sanofi Announce Cemiplimab (REGN2810) Has Received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 7 Sep 2017
Spinal Resources, Inc.'s Swedge Pedicle Screw System Receives FDA 510(k) Clearance
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 7 Sep 2017
Hereditary Cancer Risk Assessment Is an Important Option for Prostate Cancer Patients during Prostate Cancer Awareness Month
Diagnostics Oncology

HSMN NewsFeed - 6 Sep 2017
RXi Pharmaceuticals Announces Completion of Enrollment of Phase 2 Clinical Trial with Samcyprone for Cutaneous Warts
Biopharmaceuticals Dermatology

HSMN NewsFeed - 5 Sep 2017
Biocept Launches Liquid Biopsy Test for NRAS Mutations
Diagnostics Oncology Product Launch

HSMN NewsFeed - 5 Sep 2017
Mavenclad (Cladribine Tablets) Demonstrates Sustained Disease Control over 4 Years with Maximum of Only 20 Days Oral Treatment
Biopharmaceuticals Neurology

HSMN NewsFeed - 31 Aug 2017
MiMedx Reports MultiCenter randomized Controlled VLU Clinical Study Accepted for Publication in The International Wound Journal
Biopharmaceuticals Regenerative Medicine Wound Care

HSMN NewsFeed - 29 Aug 2017
ARMO BioSciences Raises $67 Million in a Series C-1 Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 25 Aug 2017
European Commission Grants Approval for Mavenclad (Cladribine Tablets)
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 21 Aug 2017
Perrigo Announces Final FDA Approval and Settlement for the Store Brand OTC Equivalent of Nexium(R) 24HR Capsules
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 16 Aug 2017
Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog(R) II Cream
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 15 Aug 2017
Philips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
Devices Monitoring

HSMN NewsFeed - 14 Aug 2017
Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
Diagnostics Oncology Distribution

HSMN NewsFeed - 10 Aug 2017
Biocept Announces Private Placement of $2.2 Million of Common Stock with Ally Bridge LB Healthcare Master Fund
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 7 Aug 2017
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Biopharmaceuticals Drug Delivery FDA

Return to NewsFeed

Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 500 additional stories matching:
Elan
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.